Correlation Between PTC Therapeutics and Iovance Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PTC Therapeutics and Iovance Biotherapeutics, you can compare the effects of market volatilities on PTC Therapeutics and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and Iovance Biotherapeutics.
Diversification Opportunities for PTC Therapeutics and Iovance Biotherapeutics
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between PTC and Iovance is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and Iovance Biotherapeutics go up and down completely randomly.
Pair Corralation between PTC Therapeutics and Iovance Biotherapeutics
Given the investment horizon of 90 days PTC Therapeutics is expected to generate 0.57 times more return on investment than Iovance Biotherapeutics. However, PTC Therapeutics is 1.75 times less risky than Iovance Biotherapeutics. It trades about 0.02 of its potential returns per unit of risk. Iovance Biotherapeutics is currently generating about -0.34 per unit of risk. If you would invest 4,588 in PTC Therapeutics on November 2, 2024 and sell it today you would earn a total of 27.00 from holding PTC Therapeutics or generate 0.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
PTC Therapeutics vs. Iovance Biotherapeutics
Performance |
| Timeline |
| PTC Therapeutics |
| Iovance Biotherapeutics |
PTC Therapeutics and Iovance Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PTC Therapeutics and Iovance Biotherapeutics
The main advantage of trading using opposite PTC Therapeutics and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.| PTC Therapeutics vs. Surrozen | PTC Therapeutics vs. Armata Pharmaceuticals | PTC Therapeutics vs. Pasithea Therapeutics Corp | PTC Therapeutics vs. Aditxt Inc |
| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |